W R McCabe

Author PubWeight™ 89.84‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Gram-negative bacteremia. III. Reassessment of etiology, epidemiology and ecology in 612 patients. Am J Med 1980 4.45
2 Comparison of the antibacterial activity of rifampicin and other antibiotics. Am J Med Sci 1968 3.03
3 Gram-negative bacteremia. IV. Re-evaluation of clinical features and treatment in 612 patients. Am J Med 1980 3.03
4 Immunization with R mutants of S. Minnesota. I. Protection against challenge with heterologous gram-negative bacilli. J Immunol 1972 2.89
5 Limitations of the usefulness of the Limulus assay for endotoxin. N Engl J Med 1973 2.84
6 Escherichia coli in bacteremia: K and O antigens and serum sensitivity of strains from adults and neonates. J Infect Dis 1978 2.72
7 Nosocomial pneumonia in intubated patients given sucralfate as compared with antacids or histamine type 2 blockers. The role of gastric colonization. N Engl J Med 1987 2.64
8 Activation of the properdin pathway of complement in patients with gram-negative of bacteremia. N Engl J Med 1975 2.63
9 Pseudobacteremia caused by povidone-iodine solution contaminated with Pseudomonas cepacia. N Engl J Med 1981 2.56
10 Type-specific and cross-reactive antibodies in gram-negative bacteremia. N Engl J Med 1972 2.42
11 Extrapulmonary tuberculosis revisited: a review of experience at Boston City and other hospitals. Medicine (Baltimore) 1984 2.28
12 Bacterial infections in adult patients with the acquired immune deficiency syndrome (AIDS) and AIDS-related complex. Am J Med 1987 2.04
13 Risk factors for pneumonia and fatality in patients receiving continuous mechanical ventilation. Am Rev Respir Dis 1986 2.04
14 Serum complement levels in bacteremia due to gram-negative organisms. N Engl J Med 1973 1.70
15 The relation of K-antigen to virulence of Escherichia coli. J Infect Dis 1975 1.64
16 Nosocomial infection and fatality in medical and surgical intensive care unit patients. Arch Intern Med 1988 1.58
17 Immunization with R mutants of Salmonella minnesota. II. Serological response to lipid A and the lipopolysaccharide of Re mutants. Infect Immun 1977 1.56
18 Nephrotoxicity associated with cephalothin administration. Arch Intern Med 1975 1.40
19 Immunization with R mutants of Salmonella minnesota. II. Comparison of the protective effect of immunization with lipid A and the Re mutant. Infect Immun 1977 1.39
20 An outbreak of type 1 pneumococcal pneumonia in a men's shelter. JAMA 1980 1.38
21 Bacteremia due to Fusobacterium species. Am J Med 1983 1.35
22 Pseudobacteremia traced to cross-contamination by an automated blood culture analyzer. Infect Control 1984 1.33
23 Mycobacterial cervical lymphadenopathy. Relation of etiologic agents to age. JAMA 1984 1.31
24 Immunization with rough mutants of Salmonella minnesota. IV. Protection by antisera to O and rough antigens against endotoxin. J Infect Dis 1983 1.29
25 Common enterobacterial antigen. I. Isolation and purification from Salmonella typhose 0:901. J Immunol 1973 1.28
26 "Abacterial" and bacterial pyelonephritis. Immunofluorescent localization of bacterial antigen. N Engl J Med 1969 1.28
27 A large outbreak of infections caused by a strain of Staphylococcus aureus resistant of oxacillin and aminoglycosides. Am J Med 1981 1.28
28 Meningitis caused by gram-negative bacilli. Ann Intern Med 1980 1.27
29 Vancomycin treatment of bacteremia caused by oxacillin-resistant Staphylococcus aureus: comparison with beta-lactam antibiotic treatment of bacteremia caused by oxacillin-sensitive Staphylococcus aureus. J Infect Dis 1983 1.24
30 Effects of IgM and IgG antibody in patients with bacteremia due to gram-negative bacilli. J Infect Dis 1976 1.24
31 M proteins of group G streptococci isolated from bacteremic human infections. Infect Immun 1987 1.24
32 Selective pressures and lipopolysaccharide subunits as determinants of resistance of clinical isolates of gram-negative bacilli to human serum. Infect Immun 1987 1.20
33 Contaminated medication nebulizers in mechanical ventilator circuits. Source of bacterial aerosols. Am J Med 1984 1.14
34 Immunofluorescent demonstration of the common enterobacterial antigen. Proc Soc Exp Biol Med 1966 1.12
35 Meningitis caused by Acinetobacter calcoaceticus var anitratus. A specific hazard in neurosurgical patients. Arch Neurol 1981 1.11
36 Cross-reactive antigens: their potential for immunization-induced immunity to Gram-negative bacteria. J Infect Dis 1977 1.07
37 Bacteremia due to Mycobacterium tuberculosis in patients with human immunodeficiency virus infection. A report of 9 cases and a review of the literature. Medicine (Baltimore) 1990 1.05
38 Immunization with rough mutants of Salmonella minnesota: initial studies in human subjects. J Infect Dis 1988 1.04
39 Gram-negative bacteremia. Adv Intern Med 1974 1.00
40 Common enterobacterial antigen. 3. Initial titers and antibody response in bacteremia caused by gram-negative bacilli. Infect Immun 1973 0.93
41 Immunofluorescent localization of bacterial antigen in pyelonephritis. I. The use of antisera against the common enterobacterial antigen in experimental renal lesions. J Lab Clin Med 1967 0.93
42 Endotoxin and bacteremia due to gram-negative organisms. N Engl J Med 1970 0.91
43 Bacteremia caused by group G streptococci in parenteral drug abusers: epidemiological and clinical aspects. J Infect Dis 1986 0.90
44 Contamination of mechanical ventilators with tubing changes every 24 or 48 hours. N Engl J Med 1982 0.89
45 Bacterial interference induced in embryonated eggs by staphylococci. J Clin Invest 1967 0.88
46 Common enterobacterial antigen. II. Effect of immunization on challenge with heterologous bacilli. Infect Immun 1973 0.87
47 Antibiotics and endotoxic shock. Bull N Y Acad Med 1975 0.84
48 Naloxone versus placebo in treatment of septic shock. Lancet 1985 0.83
49 Methicillin-resistant Staphylococcus aureus bacteremia linked to intravenous drug abusers using a "shooting gallery". Am J Med 1986 0.83
50 A randomized study comparing a transparent polyurethane dressing to a dry gauze dressing for peripheral intravenous catheter sites. Infect Control 1985 0.83
51 Clinical use of combinations of antimicrobial agents. Antimicrob Agents Chemother (Bethesda) 1967 0.82
52 Endotoxin-associated protein: a potent stimulus for human granulocytopoietic activity which may be accessory cell independent. Infect Immun 1988 0.81
53 Interactions of rifampin and trimethoprim in vitro. Rev Infect Dis 1982 0.81
54 Endotoxin-associated protein: interleukin-1-like activity on serum amyloid A synthesis and T-lymphocyte activation. Infect Immun 1988 0.80
55 Randomized clinical trial of aztreonam and aminoglycoside antibiotics in the treatment of serious infections caused by gram-negative bacilli. Antimicrob Agents Chemother 1989 0.80
56 The role of lipopolysaccharide of gram-negative bacilli in sensitivity and resistance to serum. Prog Clin Biol Res 1988 0.80
57 Pathophysiology of bacteremia. Am J Med 1983 0.79
58 Xanthogranulomatous pyelonephritis caused by methicillin-resistant Staphylococcus aureus. Am J Med 1984 0.79
59 Gram-negative bacteremia. Dis Mon 1973 0.79
60 Potential use of shared antigens for immunization against gram-negative bacillary infections. Prog Clin Biol Res 1980 0.78
61 Studies of staphylococcal infections. II. The role of bacteriophage type, antibiotic resistance, coagulase, and other exotoxins in infections in embryonated eggs. Yale J Biol Med 1966 0.78
62 Empiric therapy for bacterial meningitis. Rev Infect Dis 1983 0.77
63 Ototoxicity of erythromycin. Lancet 1978 0.77
64 Antibody to endotoxin in the treatment of gram-negative sepsis. JAMA 1992 0.77
65 Humoral immunity to gram-negative bacillary infections in experimental animals and man. Infection 1975 0.76
66 A model for bacterial clearance in the lung. Surgery 1972 0.75
67 In vitro studies of moxalactam (LY127935), a new beta-lactam antibiotic with significant activity against gram-negative bacteria. Infection 1980 0.75
68 Naloxone in septic shock. Lancet 1985 0.75
69 The correlation of in vitro tests with the outcome of antimicrobial therapy for otitis media. Pediatr Ann 1984 0.75
70 Trichinosis. Report of a small outbreak with observations of thiabendazole therapy. Arch Intern Med 1967 0.75
71 Letter: Incidence of gram-negative bacteremia. N Engl J Med 1975 0.75
72 Immunoprophylaxis of gram-negative bacillary infections. Annu Rev Med 1976 0.75
73 Role of the reticuloendothelial system in bacterial interference in embryonated eggs. J Lab Clin Med 1968 0.75
74 University of California/Davis Interdepartmental Conference on gram-negative septicemia. Rev Infect Dis 1991 0.75
75 Detection of bacterial antigen in bacterial and "abacterial" pyelonephritis. Trans Assoc Am Physicians 1969 0.75
76 Gram-negative rod bacteremia in cancer patients. A review with emphasis on the antibody response. Eur J Cancer 1975 0.75
77 A clinical study of moxalactam in the treatment of infections due to gram-negative bacilli. Scand J Infect Dis 1984 0.75
78 Adult bacteremia caused by gram-negative bacilli. Clin Obstet Gynecol 1979 0.75